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The CACNA1A gene, encoding the voltage-gated
calcium channel subunit a1A, is involved in pre-
and postsynaptic Ca2+ signaling, gene expression,
and several genetic neurological disorders. We
found that CACNA1A coordinates gene expression
using a bicistronic mRNA bearing a cryptic internal
ribosomal entry site (IRES). The first cistron encodes
the well-characterized a1A subunit. The second ex-
presses a transcription factor, a1ACT, which coordi-
nates expression of a program of genes involved in
neural and Purkinje cell development. a1ACT also
contains the polyglutamine (polyQ) tract that, when
expanded, causes spinocerebellar ataxia type 6
(SCA6). When expressed as an independent poly-
peptide, a1ACT—bearing an expanded polyQ
tract—lacks transcription factor function and neurite
outgrowth properties, causes cell death in culture,
and leads to ataxia and cerebellar atrophy in trans-
genic mice. Suppression of CACNA1A IRES function
in SCA6 may be a potential therapeutic strategy.
INTRODUCTION
Voltage-gated calcium channel genes encode a large family of
channel proteins (a1 subunits) that play critical roles in neuronal
excitability, transmitter release, muscle contractility, and gene
expression (Catterall, 2011). Genetic defects of these channels
have been implicated in a variety of neurological, cardiac, and
skeletal muscle disorders (Cain and Snutch, 2011). Diverse
mutations in the a1A subunit, CACNA1A gene, causing either
loss or gain of P/Q-type channel function, have been associated
with dominantly inherited conditions of migraine, epilepsy, and
episodic and progressive ataxia (Rajakulendran et al., 2012).
The recognition that spinocerebellar ataxia type 6 (SCA6) is
due to expansion of a polyglutamine (polyQ) tract encoded by
a newly identified 47th exon in CACNA1A, from a normal range118 Cell 154, 118–133, July 3, 2013 ª2013 Elsevier Inc.of Q4–Q17 to a pathological range of Q19–Q33, added further
complexity to modeling both channel function and disease
pathogenesis (Zhuchenko et al., 1997).
Attempts to attribute SCA6 to a disturbance in P/Q-type chan-
nel function associated with the expanded polyQ in the a1A
subunit in heterologous expression systems have led to contra-
dictory results, whereas two knockin studies showed no effect of
expanded polyQ tracts on P/Q channel gating (Saegusa et al.,
2007; Watase et al., 2008). Several laboratories have shown
that the C terminus of the a1A subunit (a1ACT), which contains
the polyQ tract, is present as a stable fragment in cultured cells
or cerebellar tissues (Ishiguro et al., 2010; Kordasiewicz et al.,
2006; Kubodera et al., 2003; Marque`ze-Pouey et al., 2008; Scott
et al., 1998) and enriched in cerebellar nuclei, based on nuclear
localization signals in the a1ACT sequence (Kordasiewicz et al.,
2006). This finding is similar to that of the C-terminal fragment of
the L-type subunit that is translocated to the nucleus and
functions as a transcription factor (Gomez-Ospina et al., 2006).
Finally, the a1ACT fragment bearing SCA6-expanded polyQs
is toxic to cultured cells and primary neurons (Ishiguro et al.,
2010; Kordasiewicz et al., 2006; Kubodera et al., 2003;
Marque`ze-Pouey et al., 2008).
Here, we explored the origin and function of the a1ACT poly-
peptide in physiology and disease. We demonstrate that
a1ACT is generated from the full-length a1A transcript by means
of a cellular internal ribosomal entry site (IRES) located within the
a1A messenger RNA (mRNA), i.e., that the CACNA1A gene is
bicistronic. The a1ACT protein containing the normal polyQ tract
is a transcription factor that binds and enhances expression of
several Purkinje cell (PC)-expressed genes, promotes neurite
outgrowth, and partially rescues theCACNA1A knockout pheno-
type. a1ACT with expanded polyQ has altered function, reduces
viability of cells in vitro, and causes gait impairment and
cerebellar cortical atrophy in vivo. We identify a truly bicistronic,
dual-function cellular gene encoding two proteins with
completely distinct functions: in this case, an ion channel and
a transcription factor. This gene expression strategy demon-
strates a role for an IRES in coordinating gene expression as
well as a potential therapeutic target for disease-modifying
therapy.
RESULTS
Identification of the C-Terminal Fragment of the
CACNA1A-Encoded a1A Subunit
To identify the N-terminal sequence of the a1ACT fragment, we
tagged the full-length human a1A subunit complementary DNA
(cDNA) bearing normal polyQ (Q11), a1AWT, at its 3
0 end with a
3xFLAG epitope and established HEK293 cell lines stably ex-
pressing this 220 kDa a1A-FLAG fusion protein. The cell line
grew normally and stably expressed the 75 kDa a1ACT-FLAG
fusion protein. We affinity purified a1ACT-FLAG from the
whole-cell lysate in a two-step procedure. Peak elution fractions
(Figure 1A) collected from anion exchange chromatography
(HiTrap DEAE FF) were subjected to affinity purification using
anti-FLAG M2 magnetic beads. The isolated a1ACT fragment
protein was seen as a unique 75 kDa band (arrowhead)
above the heavy-chain immunoglobulin G (IgG) band on a
Coomassie-stained SDS-PAGE gel (Figures 1B and 1C). Liquid
chromatography-tandem mass spectrometry (LC-MS/MS) anal-
ysis of in-gel digest protein (The Rockefeller University Protein
Resource Center) revealed that the amino acid sequence of
N terminus of a1ACT fragment was Met Ile Met Glu Tyr (amino
acids 1,960–1,964, nucleotides 6,114–6,128, GenBank acces-
sion numbers 187828892 and NM_001127222) (Figure 1D; Fig-
ure S1 available online). This sequence, which begins within the
IQ-like domain of the full-length a1A subunit and does not over-
lap with any known protease cleavage site, is a highly homolo-
gous sequence in all vertebrate species (Wilkins et al., 1999).
To investigate the origin of the a1ACT protein fragment, we
generated a series of constructs bearing different mutations of
the a1A cDNA, as defined in Figure 1E, and transfected them
into HEK293 cells. Deletion of 534 bps (a1Adel534bp) abolished
the a1ACT fragment expression without affecting the expression
of the full-length a1A subunit (Figure 1H), whereas other muta-
tions of a1A failed to do so (Figures 1E–1H). This indicates that
the 534 bp fragment upstream of the a1ACT start site in the
a1A cDNA contains sequences essential for translation of
a1ACT. These effects on expression were seen to an equivalent
degree with both the a1AWT and the human a1A subunit cDNA
bearing the pathological polyQ tract (Q33, a1ASCA6).
CACNA1A mRNA Contains an Internal Ribosome
Entry Site
We hypothesized that expression of a1ACT fragment may be
mediated by an IRES present within the CACNA1A coding
sequence. Two-dimensional structure analyses of the complete
a1AmRNA sequence using anM-fold-based algorithm (Palmen-
berg and Sgro, 1997; Zuker, 2003) did not identify any canonical
type I or type II IRES structures in this region (Baird et al., 2006).
However, the region containing nucleotides 5,096–6,110 was
predicted to form a highly complex, stable conformation pos-
sessing several stem-loop structures that could represent an
area of functional significance for ribosomal binding and interac-
tion with trans-activating factors (Figure S2). This region is highly
conserved, from 89.4% in Bos taurus to 76.7% in Danio rerio
(data not shown).
To test for IRES activity within this region, we inserted DNA
segments of different lengths (Figure 2) from the region 50 tothe a1ACT start site into the bicistronic (Renilla luciferase,
R-Luc, and firefly luciferase, F-Luc) reporter vector, pRF (Fig-
ure 2A) (Spriggs et al., 2009). Because the coding region for
the R-Luc is followed by a stop codon, an increase in F-Luc
activity indicates the presence of an upstream IRES that enables
rebinding of the dual luciferase transcript to the ribosomal
machinery. Expression of pRCT653TF or pRCT1014TF, but not
pRCT189TF and pRCT293TF, in HEK293 cells enhanced the
activity of the F-Luc approximately 9- and 26-fold (Figures 2A
and 2B). Moreover, insertion of 1 or 2 nucleotides immediately
50 to the ATG codon prior to the F-Luc coding region within the
pRF vector eliminated the accumulation of F-Luc (Figures 2C
and 2D). Therefore, the structure of the CACNA1A IRES is highly
dependent on initiating translation of the second cistron at
a specific codon, ATG 1960, as is typical of most IRES activation
(Fitzgerald and Semler, 2009; Wilson et al., 2000). To help
exclude the possibility that the increased F-Luc activity was
due to a change at the RNA level, we inserted the same
segments into the promoterless reporter vector, pGL3Basic.
Transfection into HEK293 cells yielded no significant increase
of luciferase activity (Figures 2E–2G), arguing against the
presence of a cryptic promoter in these segments. Subse-
quently, we performed quantitative real-time PCR on two
amplicons within the Renilla open reading frame (ORF) and one
near the initiation codon of firefly ORF (Figure 2A). The observed
ratio of 1:1 Renilla:Firefly mRNA (Figure 2H) favors the presence
of an IRES, rather than increased transcription of the second
reporter via a cryptic promoter, a splicing event or any other
increase in mRNA stability. In addition, the quantitative real-
time PCR expression ratios for gene fragments (50 to or 30 to
the a1ACT start site) within the a1A subunit were approximately
one in untransfected HEK293 or PC12 cells. Lastly, we found
equivalent signals from before and after the a1ACT start site
using endogenous a1A mRNA isolated from human cerebellum
(Figures 2I and 2J). These results suggest that expression of
a1ACT is driven by the presence of a cellular IRES within the
a1A coding region rather than by a cryptic promoter or splicing
event.
The Translocated a1ACT Fragment Binds to Noncoding
Regions of Genes Expressed in Purkinje Cells and
Activates Transcription
Earlier studies indicated that the 75 kDa a1ACT, bearing the
normal polyQ tract, was enriched in the nucleus (Ishiguro et al.,
2010; Kordasiewicz et al., 2006). To investigate whether
a1ACTWT (Q11) plays a role in gene expression by binding to
genomic DNA, we performed chromatin immunoprecipitation-
based cloning (ChIP-based cloning) from PC12 cells transfected
with a1ACT-FLAG fusion protein (Experimental Procedures).
Potential target genes identified via ChIP-based cloning and
sequencing include granulin (GRN), B cell translation gene 1
(BTG1), Ca2+ ATPase, plasma membrane 2 (PMCA2), integrin
a-8 precursor (ITGA8), and TATA box binding protein-associated
factor of RNA pol II (TAF1) (Table S2). Putative interaction
between a1ACT-FLAG fusion protein and cloned DNA segments
within theBTG1, PMCA2, andGRN genes was further confirmed
by ChIP quantitative real-time PCR (Figures 3A and 3B).
Although these genes are not uniquely expressed in PCs, theCell 154, 118–133, July 3, 2013 ª2013 Elsevier Inc. 119
Figure 1. The C-Terminal Fragment of the a1A Subunit Initiates at MIMEY, Amino Acids 1,960–1,964, Nucleotides 6,114–6,128
(A) Western blot analysis of fractions collected fromHiTrap DEAE FF anion exchange chromatography. A 3xFLAG-tagged a1A subunit is used as positive control.
(B) Coomassie blue staining of the peak a1ACT-containing fraction after two-step purification. The arrowhead indicates the 75 kDa band identified by mass
spectrometry as a1ACT.
(C) Western blot analysis of lysate from a1A-overexpressing cells with anti-FLAG antibody confirms the identity of a1ACT.
(D) LC-MS/MS analysis of in-gel digest of proprionylated protein reveals that the starting amino acid sequence of N terminus of the a1ACT fragment is Met Ile
Met Glu Tyr.
(E) Schematic representation of the constructs with a series of mutations or deletions.
(F) In-frame deletion of the start site of a1ACT does not abolish the expression of the 75 kDa C-terminal portion of the FLAG-tagged a1A protein bearing either
normal range (Q11) or pathological range (Q33) of polyQ.
(G) Expression of the 75 kDa a1ACT C-terminal fragment persists after insertion of termination codons at T1937 or P1847 in the FLAG-tagged a1A subunit,
upstream of the start site.
(legend continued on next page)
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abundant expression of a1ACT in PCs suggests that they are
part of a PC-specific developmental program.
We tested whether a1ACT regulates gene expression through
the target sequences identified in ChIP-based cloning.Within the
BTG1 30 UTR, we identified an enhancer within the 113 bp
sequence that was obtained from a1ACT ChIP-based cloning,
using reporter assays with segments spanning three lengths
(beginning at 517 nt) from the 30 UTR inserted into the pGL3
promoter vector (Du et al., 2009), as shown in Figure 3C. Impor-
tantly, overexpression of a1ACTWT significantly increased
luciferase activity in the BTG1-630 reporter construct, suggest-
ing that BTG1 30 UTR contains an a1ACT-regulated enhancer
element. However, a1ACTSCA6, bearing the pathological polyQ
tract (Q33) failed to increase BTG1 30 UTR-enhanced luciferase
expression (Figure 3C). We obtained similar results from two
segments of 50 flanking region in the progranulin gene using
the pGL3-basic vector. The a1ACTWT fragment, but not the
a1ACTSCA6 fragment, increased expression of the reporters
bearing the 1,662 bp fragment by 2-fold and the 638 bp fragment
by 3.2-fold (Figure 3D). Thus, a1ACTWT has direct gene regulato-
ry effects on at least two target genes, and these are lacking with
a1ACTSCA6.
AT-Rich Element of a1ACT Binding Site Is Essential for
the BTG1 Enhancer Activity
Alignments of ChIP-identified sequences predict two distinct
motifs, (1) an AT-rich element, TTATAAAA, and (2) a CA-rich
element, CCAA, as potential a1ACT binding sites (Figure 3E).
The 113 bp BTG1 30 UTR sequence (517–630 bps BTG1 wild-
type [WT]; Table S3) contains both consensus sequences. As
shown in Figure 3F by electrophoretic mobility shift assays
(EMSA) using the BTG1 WT as probe and nuclear extracts
from untreated PC12 cells or from those transfected with
a1ACTWT and a1ACTSCA6, we observed a component in PC12
cells, caused a significant gel shift (complexes I, II, and III).
This indicates that the BTG1 30 UTR contains cis-elements
reactingwith neuron-specific nuclear protein, present in both un-
transfected and a1ACT-transfected cells. The three protein
complexes with the BTG1 WT probe could be abolished by an
excess unlabeled BTG1 WT probe, indicating that the binding
was specific (lanes 3 and 4, Figure 3F). Interestingly, nuclear
extracts from a1ACTSCA6-transfected PC12 cells (lane 8, Fig-
ure 3F) led to a different migration and pattern of DNA-protein
complexes compared to a1ACTWT-expressing cells (lane 5, Fig-
ure 3F), with a greater abundance of complex IV in complexes
from the a1ACTSCA6-transfected PC12 cells. This suggests
that a1ACTSCA6 has a different protein binding pattern from
a1ACTWT.
To further identify a1ACT consensus sequences, we used the
AT-rich consensus element as a probe in EMSA (Table S3; Fig-
ure 3G). The AT-rich consensus sequence greatly reduced the
formation of the complexes (lane 7, Figure 3G), whereas mutant
AT-rich elements only partially reduced the complex formation(H) Deletion of a 534 bp fragment (a1Adel534Q11), but not deletion of a 185 bp f
eliminates a1ACT expression, whilemaintaining expression of full-length a1A-FLA
and a1Adel534Q33) behave similar to the Q11 constructs.
See also Figure S1.(lanes 5 and 6, Figure 3G). Anti-FLAG antibodies generated
a super-shifted complex with nuclear extracts from a1ACTWT-
FLAG-expressing cells (lanes 8 and 9, Figure 3G). These studies
demonstrate that a1ACT binds to an AT-rich element in the
BTG1 30 UTR. Finally, we performed EMSA with a series of
3 bp mutations of the TTATAAGAT sequence (Table S3). As
shown in Figure 3H, Mut1 abolished complex II and Mut2 abol-
ished complex I. Mut4, combining Mut1 and Mut2, abolished
both complexes I and II (Figure S3). We also mutated the
element, TTATAAGT, within the BTG1-630 reporter construct
(517–630 bp). Constructs 630mut1 and 630mut2 contain 3 bp
mutation, whereas 630mut4 contains both Mut1 and Mut2 sub-
stitutions. All three constructs had significantly reduced lucif-
erase activities, both basally and in response to overexpressing
of a1ACTWT compared to BTG1 630 construct (Figure 3I). These
results suggest that TTATAA is the core sequence of the AT-rich
element that is required to maintain the a1ACT-regulated BTG1
expression.
The a1ACTWT, but Not a1ACTSCA6, Increases the
Physiological Expression of Target Genes and Enhances
Neurite Outgrowth of Differentiating PC12 Cells
To test for an effect of a1ACT on endogenous expression of
ChIP-identified genes, we examined the mRNA and protein
levels of TAF, BTG1, PMCA2, and GRN in both cell lines
and human cerebellum. Overexpression of normal a1AWT or
a1ACTWT, but not a1ACTSCA6, significantly increased the
expression of these genes (1.6- to 2.7-fold) in PC12 cells, either
compared to empty vector-transfected or a1ACTSCA6-trans-
fected PC12 cells (Figure 4A). As shown in Figures 4B and 4C,
BTG1 and PMCA2 protein expression levels were also increased
in a1AWT- and a1ACTWT-transfected PC12 cells. Finally, using
cerebellar tissues from two SCA6 patients (Q22) and normalizing
transcript levels to a PC-specific mRNA, Pcp2, we found that
BTG1 gene mRNA expression was decreased compared to the
normal control (Figure 4D).
Several of the genes regulated by a1ACT are known to play a
role in differentiation of the neuronal phenotype (Baker
et al., 2006). We established PC12 cell lines stably expressing
3xFLAG-tagged versions of either the full-length a1A or the
a1ACT fragment. Upon induction with nerve growth factor
(NGF) for 24 hr, we observed that both a1AWT-FLAG and
a1ACTWT-FLAG enhanced neurite outgrowth (fraction of cells
with neurites) when compared with PC12 cells expressing empty
vector (Figures 4E–4H; Figures S4A–S4D). Importantly, the P/Q
channel blocker,u-agatoxin, had no effect on a1ACTWT-induced
neurite outgrowth (Figure S4E). Furthermore, blocking the
expression of endogenous or transfected full-length a1A by
small interference RNA (siRNA) had no effect on a1ACTWT-
enhanced neurite outgrowth in PC12 cells transfected with
a1ACTWT-FLAG (Figures S4E–S4K). These findings suggest
that enhanced neurite outgrowth does not depend on func-
tioning channels or the presence of the full channel protein.ragment (a1Adel185Q11), from the a1A coding region upstream of the a1ACT
G. Deletions using encodedQ33 repeat expansions constructs (a1Adel185Q33
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Figure 2. CACNA1A mRNA Contains an IRES
(A) Schematic representation of the constructs pRF and pRCTTF.
(B) IRES activity is demonstrated using bicistronic vectors. The ratio of Renilla luciferase and firefly luciferase activities was determined and normalized to
b-galactosidase activities.
(C) Sequence of CACNA1A IRES nucleotide inserts CTT, CTmut1, and CTmut2, inserting of 1 to 2 nucleotides.
(D) The luciferase activities of bicistronic vectors bearing nucleotide insertions are determined as in (B).
(E) Schematic representation of the constructs pGL3Basic and pGL3BasicCT. The same DNA fragments as inserted into pRF were subcloned into the
promoterless pGL3Basic construct.
(F) Luciferase activities are determined as in (B).
(G) The raw firefly luciferase activities of two fragments are compared between promoterless vector pGL3BasicCT and bicistronic vector pRCTTF, which
suggests that the 1,014 bp fragment contains an IRES.
(legend continued on next page)
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There was a significant increase in the percentage of cells
bearing neurites in cells transfected with a1AWT-FLAG and
a1ACTWT-FLAG compared to controls after NGF stimulation
for 24, 48, and 72 hr (Figures 4E, 4F, and 4H). Total neurite
lengths were also increased 2-fold in a1ACTWT-expressing cells
compared with controls at each time point (Figure 4G; Figures
S4A–S4D). However, cells expressing a1ACTSCA6-FLAG had
significantly lower percentage of cells with neurites and total
neurite length/cell compared with cells expressing a1ACTWT-
FLAG (Figures 4E–4H; Figures S4A–S4D). Thus, a1ACTSCA6
lacks the normal function of a1ACTWT in potentiating neurite
outgrowth in neuronal cells.
BTG1 belongs to the BTG/TOB protein family of antiprolifera-
tive genes. Both BTG1 and BTG2 proteins interact with the pro-
tein arginine N-methyltransferase (i.e., PRMT1) and positively
modulate its activity. The PRMT1/BTG methylation pathway is
involved in maintaining neuronal cells in a differentiated state
(Berthet et al., 2002). We used BTG1 antibody to immunoprecip-
itate PRMT1 in PC12 cells stably transfected with a1ACTWT and
a1ACTSCA6. In a1ACTWT-expressing cells, the quantity of precip-
itated PRMT1was increased, whereas in a1ACTSCA6-expressing
cells, precipitated PRMT1 was decreased, consistent with the
expression of BTG1 in these two cell types (Figure 4I). Mean-
while, silencing of BTG1 by siRNA blocked the NGF-induced
a1ACT-regulated neurite outgrowth (Figures 4J–4L; Figure S4L).
These results demonstrate that a1ACT with normal range polyQ
maintains the physiological expression of the BTG1 gene,
leading to subsequent interaction of the PRMT1/BTG pathway
to mediate neuronal differentiation. Together, these observa-
tions suggest that the normal a1ACT acts as a transcription fac-
tor through target genes to enhance the neuronal phenotype and
that one effect of the SCA6 polyQ expansion in a1ACT is to
disrupt the properties of the a1ACT transcription factor.
a1ACT Partially Rescues the Phenotype of a1A/ Mice
a1A/ mice, with targeted disruption of mouse CACNA1A,
develop a gross neurological phenotype of seizures, dystonia,
and ataxia soon after birth and die by P18–P21 (Jun et al.,
1999). To investigate the importance of expression of the
a1ACT fragment in PCs, we used the Pcp2 promoter and Tet-off
system (Zu et al., 2004) to generate twodouble transgenicmouse
lines, Pcp2-tTA/TRE-a1ACT (abbreviated, PC-a1ACT), express-
ing at comparable levels either a1ACTWT (WT = Q4, the smallest
a1ACT polyQ seen in humans) or a1ACTSCA6 (SCA6 = Q33, the
largest a1ACT polyQ seen in SCA6) fragments tagged with an
N-terminal myc epitope (see Experimental Procedures). These
mice appeared to grow and develop normally and live a full life-
span. a1ACTSCA6 mice, however, had mild progressive motor
problems that were evident using the treadmill (see below).
To test the role of a1ACT in cerebellar PC development in the
absence of a1A channels, we bred PC-a1ACT mice with a1A+/(H) Quantitative real-time PCR performed using RNA from cells transfectedwith bi
no difference in abundance of R-Luc and F-Luc mRNA.
(I and J) Quantitative real-time PCR performed using RNA extracted from PC1
abundance of amplicons Ex34–35, Ex38–39, and Ex39–40 upstream of the a1AC
a1ACT coding region. Data are mean ± SEM, nR 3 (each involving triplicate ass
See also Figure S2.heterozygous knockout mice and subsequently crossed these
offspring to generate a1A/ mice with PC-targeted a1ACT
expression (a1A//PC-a1ACT). Curiously, we did not identify
any mice with a1A//PC-a1ACTSCA6 genotype, suggesting an
impaired viability (Figure 5A). As expected, a1A/ exhibited
severe neurological impairment (Jun et al., 1999). Surprisingly,
a1A/ mice expressing a1ACTWT, i.e., a1A
//PC-a1ACTWT
mice, had an improved behavioral phenotype relative to
a1A/ mice. Although still neurologically impaired, they gained
more weight during the first 2 weeks of postnatal life compared
to a1A/ mice (Figures 5B and 5C), had improved in-cage
mobility (Movie S1), and survived 1 week longer than a1A/
mice (Figure 5D). We reasoned that the improved phenotype of
a1A//PC-a1ACTWT mouse might be mediated through
improved dendritic and synaptic development. Immunofluores-
cent staining of cerebellar cortex of P16 mice from three groups,
WT, a1A/, and a1A//PC-a1ACTWT mice showed that, as
noted previously, PCs of a1A/ mice had shortened primary
dendrites with premature branching and an immature pattern
of parallel fiber (PF) and climbing fiber (CF) synaptic contacts
on PC soma and proximal dendrites (Hashimoto et al., 2011)
(Figures 5E–5L). In contrast, PC morphology and afferent inner-
vation of a1A//PC-a1ACTWT cells resembled the pattern inWT
mice (Figures 5E–5L). In a1A//PC-a1ACTWT mice, the thick-
ness of molecular layer (ML), the relative height, and density of
the dendritic tree were significantly increased, compared to
those of a1A/ mice (p < 0.05) (Figures 5F–5H). This finding is
consistent with our in vitro studies showing that a1ACT
enhances neurite outgrowth.
We also compared the height of CF innervation between the
three mouse groups (Figures 5J–5L) (Hashimoto and Kano,
2005; Hashimoto et al., 2011). In a1A/ mice, most PCs were
multi-innervated, and the CF height only reached 65.2% ±
5.3% of the ML at P16. We found that the CF height was
improved in a1A//PC-a1ACTWT mice over that of a1A
/
mice, reaching to 80.7% ± 4.1% of the ML at P16 (p < 0.05).
However, a1A//PC-a1ACTWT mice exhibited the same three
patterns of CF contacts seen with a1A/ mice, mono CF on
PC dendrites, multiple CF contacts on proximal dendrites, and
multiple CF contacts on PC soma (Figure 5). These results
demonstrate that a1ACT, as a transcription factor, plays an
important role in establishing normal dendritic tree morphology
in PCs in vivo but that synapse elimination or selection of domi-
nant innervation requires either P/Q channel function or a1ACT
under its endogenous expression pattern.
Finally, we examinedmRNA levels of TAF,BTG1, PMCA2, and
GRN in the threemouse groups. Figure S5 demonstrates that the
expression of these genes was decreased in cerebellar tissue of
a1A/mice when compared to normal mice but was increased
1.5- to 3-fold in a1A//PC-a1ACTWT transgenic mice when
compared to a1A/ mice (p < 0.05), relative to either b-actincistronic vectors as amplified using primers Ren1, Ren2, and Fire demonstrates
2 and HEK293 cells, transfected with a1A or human cerebellum to compare
T start site relative to amplicons Ex41–42 (I) and Ex41–43 (J), from within the
ays, *p < 0.05, **p < 0.01).
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or Pcp2 gene expression (Figures S5A–S5D). These results indi-
cate that expression of the a1ACT target genes is impaired in
a1A/ mice and is corrected by localized expression of
a1ACTWT in PCs of transgenic mice.
a1ACT Partially Restores Parallel Fiber EPSC
Amplitude, but Not Climbing Fiber Monoinnervation
To further assess the effect of a1ACT expression on Purkinje
cell synaptic properties, we measured PF excitatory post-
synaptic current (PF-EPSC) amplitude as a function of stimulus
intensity in WT, a1A/, and a1A//PC-a1ACTWT mice (P16–
P18) in cerebellar slice preparations. Whereas PF-EPSCs from
WT were significantly larger than those from both a1A/ mice
(p < 0.01, stimulus intensities 20–55 mA) and a1A//PC-
a1ACTWT mice (p < 0.05), EPSCs from a1A
//PC-a1ACTWT
mice were greater than those from a1A/ mice (p < 0.05),
indicating that a1ACT expression improves PF synaptic connec-
tions (Figure 6A).
The inability of a1ACT to completely restore EPSC amplitudes
toWT levels could be explained by the absence of P/Q-typeCa2+
channels in PF presynaptic terminals of a1A//PC-a1ACTWT
mice, as these channels play a critical role in neurotransmitter
release at PF-Purkinje cell (PF-PC) synapses (Matsushita et al.,
2002; Mintz et al., 1995). We therefore examined the presynaptic
release properties of PF-PC synapses in a1A/ and a1A//PC-
a1ACTWT mice by measuring the paired-pulse ratios (PPRs) of
PF-EPSCs. Large PPRs are indicative of low initial release prob-
abilities and are a sign of impaired presynaptic function (Zucker
and Regehr, 2002). In accordance with observations frommouse
models harboring loss-of-function mutations in the CACNA1A
gene, a1A/ mice exhibited PPRs significantly greater than
WT at several stimulus intervals (WT to a1A/ mice: p < 0.01
for stimulus intervals of 20–100 ms, Figure 6B) (Liu and Friel,
2008; Matsushita et al., 2002). Whereas a1ACT expression did
lower PPRs closer to WT levels (a1A//PC-a1ACTWT to
a1A/ mice: p < 0.01 for stimulus intervals of 20 and 100 ms,
p < 0.05 for stimulus interval of 50 ms), the measured values
were still elevated (WT to a1A//PC-a1ACTWT: p < 0.05 for
stimulus intervals of 20 and 50 ms) (Figure 6B), suggesting
a residual presynaptic deficit.Figure 3. a1ACT Is a Transcription Factor that Regulates Neural Gene
(A) ChIP and quantitative real-time PCR verification of DNA sequences identified b
a1ACTWT.
(B) Relative enrichment was calculated as the ratio between the net intensity of ea
normalized to vehicle control input sample (nR 3).
(C) Enhancer activity of BTG1 gene fragments. Positions of the fragments are ind
(D) Promoter activity of GRN gene fragments. Positions of the fragments are ind
(E) Consensus sequence analyzed by CLC main workbench (v. 6.5) among the
labeled in red.
(F) EMSA demonstrates the formation of displaceable nucleoprotein complex with
WT probe. Lanes 2 and 5 show the three major complexes formed between BTG1
between BTG1 probe and a1ACTSCA6 nuclear protein.
(G) EMSA shows that the AT-rich probe (531–553 nt) forms three complexes in the
AT-rich sequence and partially abolished by AT-rich Mut1 and Mut3. The super-
FLAG-M2 antibodies, but not in lane of pCDNA3 nuclear extracts.
(H) EMSA shows that the TTATAA region is critical for the formation of nucleopro
(I) a1ACTWT significantly increases BTG1 enhancer activity through intact TTATA
mean ± SEM, nR 3 (each involving triplicate assays, *p < 0.05 versus control co
See also Figure S3.We also examined properties of the CF synapse onto Purkinje
cells. We observed a reduction in CF EPSC amplitudes and a
decrease in the degree of paired-pulse depression in both
a1A/ and a1A//PC-a1ACTWT mice with respect to WT,
both of which could also be due to the absence of P/Q-type
channels presynaptically (Figure 6C). Additionally, we investi-
gated whether a1ACT expression affects the process of CF
maturation. During development, Purkinje cells undergo a
competitive and activity-dependent elimination of superfluous
CF inputs until only one remains. Impairments to this process
result in the persistent innervation of Purkinje cells by multiple
climbing fibers into adulthood. We found the proportion of
Purkinje cells with multiple CF innervations to be increased in
both a1A/ and a1A//PC-a1ACTWT mice compared to WT,
a result indicating that actual P/Q-type Ca2+ channel function,
and not just expression of the C terminus, may be essential for
proper CF maturation (Watanabe and Kano, 2011) (Figure 6D).
Our results provide evidence that a1ACT expression improves
the synaptic connections of PFs, but not CFs, onto Purkinje
cells.
a1ACTSCA6 Causes Cell Death In Vitro and Mediates
Ataxia and Cerebellar Cortical Atrophy in Transgenic
Mice
Previous studies have shown that the a1A C terminus bearing an
expanded polyQ tract is toxic relative to WT a1A C terminus
when transiently overexpressed in cultured mammalian cells
(Ishiguro et al., 2010; Kubodera et al., 2003). Our flow cytometry
results showed that PC12 cells stably expressing a1ACTWT ex-
hibited equivalent viability to vector control cells, whereas cells
expressing a1ACTSCA6 had an 2-fold increase in cell death
(p < 0.05, Figure 7A–7C) (Koopman et al., 1994). Also, lactate
dehydrogenase (LDH) release was significantly higher in cells
expressing the a1ACTSCA6 compared with that of PC12 cells
expressing only pcDNA3 or a1ACTWT (Figure 7D). These findings
indicate that overexpression of a1ACT bearing pathological size
of polyQ reduces cell viability in cultured mammalian cells.
Finally, we tested whether overexpression of the SCA6-
expanded a1ACTSCA6 fragment in mice would lead to clinical
or pathological features resembling SCA6, compared withExpression through an AT-Rich Element
y ChIP cloning. PC12 cells were transfected with empty vector or FLAG-tagged
ch bound sample normalized to its input sample and the vehicle control sample
icated.
icated.
a1ACT ChIP-targeted sequences. Consensus sequence was predicted and
the a1ACT and BTG1WT (517–630 nt) element. Lane 1 is biotin-labeled BTG1
probe and a1ACTWT nuclear protein. Lane 8 shows the fourth complex formed
absence of competitor. These complexes were displaced by excess unlabeled
shifted bands were only seen in a1ACTWT-FLAG nuclear extracts treated with
tein complexes with AT-rich element.
A region. Plasmid pRL-TK is used as transfection efficiency control. Data are
nstruct).
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Figure 4. a1ACT Enhances Neurite Outgrowth by Regulating BTG1 Expression
(A) Relative mRNA expression levels of BTG1, PMCA2, TAF, and GRN in PC12 cells transfected with a1AWT, a1ACTWT, or a1ACTSCA6 (nR 3).
(B and C)Western blot (B) and quantitation of protein expression levels of BTG1 and PMCA2 in PC12 cells transfected with a1AWT, a1ACTWT, and a1ACTSCA6 (C).
(D) Relative levels of BTG1 mRNA in the cerebellum from two SCA6 patients, normalized to Pcp2.
(E and F) a1ACTWT enhances neurite outgrowth. Representative low- and high-magnification images of PC12 cells with transiently transfected pcDNA3-FLAG,
a1AWT-FLAG, a1ACTWT-FLAG, and a1ACTSCA6-FLAG at 24 hr (E) and 72 hr after NGF treatment (F). Cells were labeled for GAP-43 (green) to visualize PC12 cell
body and neurites.
(G and H) Quantitation of average neurite length and percentage of neurites per cell (n = 200; *p < 0.05 versus pcDNA3-FLAG).
(I) a1ACTWT upregulates BTG1 gene and increases PRMT1/BTG1 protein interaction.
(J and K) Silencing of BTG1 expression inhibits a1ACTWT-enhanced neurite outgrowth. Anti-FLAG staining is shown in red.
(L) Quantitation of neurite outgrowth by siBTG1 in transfected cells (n = 3, *p < 0.05). The blunted effect by a1ACTSCA6-FLAG was also diminished by BTG1
silencing. Data are mean ± SEM.
See also Figure S4.
126 Cell 154, 118–133, July 3, 2013 ª2013 Elsevier Inc.
overexpression of the fragment with normal allele size, a1ACTWT.
Both a1ACTWT and a1ACTSCA6 can be detected in the nucleus of
PCs in the corresponding PC-a1ACT lines at comparable levels
by western blot, quantitative real-time PCR, and immunostaining
(Figure 7E; Figures S6A and S6B). There were no obvious clinical
differences between these two lines in young adults, and lifespan
was not affected. However, we found that PC-a1ACTSCA6 mice
demonstrated significant abnormalities in several gait parame-
ters compared with PC-a1ACTWT mice using a video-assisted
computerized treadmill for gait analysis (DigiGait, Mouse
Specifics) (p < 0.05, after post hoc correction). Most importantly,
they exhibited an age-dependent increase in shared stance
(double support time) of hind limbs, between 3 and 9 months
old, indicating progressive instability during walking (p < 0.05,
Figure 7F; Movies S2 and S3) (Matsukawa et al., 2003; Stolze
et al., 2002). The gait disturbance never progressed to the level
of severe ataxia, although natural changes in weight gain in older
mice may have obscured an impact on normal cage activity. The
lack of severe ataxia even in 2-year-old mice is not surprising for
a model of SCA6, with an age of onset of 43–52 years. Although
we found no obvious sign of cell loss in the cerebellum in
a1ACTSCA6 mice at 2 years of age, measurement of the ML
thickness showed that a1ACTSCA6-expressing mice have signif-
icant thinning of the ML, compared with age-matched a1ACTWT
andWTmice (Figures 7G and 7H). Lastly, using quantitative real-
time PCR to examine the expression levels of ChIP-identified
genes TAF, GRN, BTG1, and PMCA2 in cerebellar tissues of
2-year-old PC-a1ACTSCA6 mice compared with age-matched
WT mice, we found that the transcript levels of each of the
a1ACT-regulated genes were decreased by between 11% and
34% (Figures S6C–S6F). These findings are the first to demon-
strate clinical and pathological changes in an animal model of
SCA6 expressing appropriate-sized pathological alleles within
a CACNA1A-encoded protein.
DISCUSSION
CACNA1A Contains a Cellular IRES
Cellular IRESs play an increasingly recognized role in the control
of eukaryote gene expression, where in many 50 UTRs they
provide alternatives to cap-dependent translation initiation dur-
ing times of cellular stress (Coldwell et al., 2001; Spriggs et al.,
2008). IRES sequences have also been detected within the
coding regions of some cellular mRNAs, leading to the expres-
sion of isoforms or distinct protein products (Cornelis et al.,
2000; Ul-Hussain et al., 2008). Together with the present report,
these observations suggest that expression of bifunctional
genes, particularly those encoding separate transcription factor
proteins in the second cistron,may be a strategy for coordinating
gene expression programs tied to individual gene products. This
could enable the timely expression of a set of genes coincident
with the appearance of key proteins during differentiation.
a1ACT, a CACNA1A-Encoded Transcription Factor,
Promotes a Neurite Outgrowth Program
As a transcription factor, the normal a1ACT enhances the
expression of at least three genes, GRN, PMCA2, and BTG1,
in PC12 cells and cerebellar tissue, potentiates NGF-mediatedneurite outgrowth in PC12 cells, and partially rescues the
CACNA1A knockout phenotype. GRN is involved in neurite
outgrowth and is critical in maintaining neuronal survival
because loss-of-function mutations of the GRN gene lead to
cell death in the frontal and temporal lobes (Baker et al., 2006;
Cruts et al., 2006; Van Damme et al., 2008). PMCA2 is highly
expressed in the cerebellum, particularly in PCs and throughout
the ML and granule cell layer (Zacharias and Kappen, 1999).
PMCA2 knockout mice exhibit vestibular and gait abnormalities
and reduced thickness of the cerebellar ML (Kozel et al., 1998).
Lack of PMCA2 also dramatically alters PCmorphology. PMCA2
is a component of mGluR1-IP3R1 signaling complex, which has
been implicated in plasticity at the PF-PC synapse (Kurnellas
et al., 2007).
The PRMT1/BTG methylation pathway is involved in neuro-
genesis or in maintaining neuronal cells in a differentiated state.
The 30 UTR of BTG1 is highly conserved throughout evolution
and plays a key role in this pathway (Rouault et al., 1993), consis-
tent with our finding that a1ACT activates a novel 30 enhancer
element of BTG1. Enhanced BTG1/PRMT1-driven arginine
methylation partly accounts for the essential role of protein
methylation during PC12 differentiation (Cimato et al., 1997),
which is in line with findings here that BTG1 knockdown blocks
neurite outgrowth. Together, these findings suggest that
a1ACTWT is essential for maintenance of neurite outgrowth
through gene-specific signaling pathways. It will be of interest
to extend our ChIP-based cloning approach using RNA-seq
methodology to more completely characterize the normal
repertoire of a1ACT-regulated genes, as well as those bound
by a1ACTSCA6.
Except for the in vivo studies, the properties of a1ACT
are similar to those demonstrated for the 70 kDa fragment,
termed CCAT, derived from the Cav1.2 channel, a1C subunit,
which may arise from a similar translational mechanism
(Gomez-Ospina et al., 2006). In that case, as well as in
ours, the set of genes regulated by these transcription
factors does not conform to an obvious functional class of
proteins but appears to be involved in elaborating key com-
ponents of the neuronal phenotype and in neurogenesis
or neurodegeneration, timed with the appearance of Ca2+
channel activity.
Phenotype Rescue of a1A/ Mice by a1ACT
The improved phenotype at behavioral, histological, and electro-
physiological levels in a1A//PC-a1ACTWT mice is remarkable,
particularly because a1ACTWT expression, under the control of
PC specific promoter, Pcp2, was only restored in PCs. Consis-
tent with these findings and our in vitro results, ChIP-identified
genes TAF, BTG1, PMCA2, and GRN were downregulated in
a1A/ mice but were increased 1.5- to 3-fold in a1A//PC-
a1ACTWT transgenic mice. These results suggest that a1ACT,
as a second gene product from CACNA1A, plays an important
role in establishing normal morphology and function of PCs.
a1ACT Expression Improves PF-PC Connections
PF-EPSC amplitudes measured in a1A//PC-a1ACTWT were
significantly greater than those observed in a1A/mice, though
they were not completely restored to WT levels, presumably dueCell 154, 118–133, July 3, 2013 ª2013 Elsevier Inc. 127
Figure 5. a1A//PC-a1ACTWT Transgenic Mice Have Improved Phenotype and Development of Cerebellar Cortex, as Compared to a1A
/
Mice
(A and B) The genotype (A) and appearance (B) of a1A//PC-a1ACTWT mice.
(C) a1A//PC-a1ACTWT mice had slightly greater body weight compared with a1A
/ mice at age of P14 (*p < 0.05).
(legend continued on next page)
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Figure 6. a1ACT Partially Restores PF-EPSC Amplitude but Does Not Affect CF Innervation or EPSC Properties
(A) PF-EPSC amplitude as a function of stimulus intensity for a1A/ (n = 9, n = 4), a1A//PC-a1ACT (n = 16, n = 6), and WT (n = 11, n = 3) mice. Top: Typical
PF-EPSCs at a stimulus intensity of 45 mA.
(B) Paired-pulse ratios as a function of stimulus interval in a1A/, a1A//PC-a1ACT, andWTmice. Inset shows an overlay of representative traces from all three
groups of mice with an interstimulus interval of 20 ms. EPSC1 from a1A//PC-a1ACT and WT mice were scaled to match the amplitude of EPSC1 from the
a1A/ mouse to facilitate comparison.
(C) Top: Representative CF-EPSCs elicited while holding at30mV. Bottom left: CF-EPSC amplitudes for a1A/ (n = 10, n = 3), a1A//PC-a1ACT (n = 11, n = 3),
and WT (n = 8, n = 3) mice. Bottom right: Paired-pulse depression of CF-EPSCs with 200 ms stimulus interval.
(D) Left: Representative traces from PCs in a1A/ and a1A//PC-a1ACTmice exhibiting multiple CF innervation. Right: Percentage of PCs exhibiting one, two,
or three discrete CF steps in a1A/ (two steps: 6/13, three steps: 1/13, n = 3), a1A//PC-a1ACT (two steps: 5/13, n = 3), andWT (two steps: 1/9, n = 3) mice. All
mice were age P16–P18. *p < 0.05, **p < 0.01. Data are mean ± SEM.to the importance of P/Q-type Ca2+ channel function to neuro-
transmitter release at PF-PC synapses (Mintz et al., 1995).
a1ACT expression also resulted in a partial reduction of PPRs(D) The lifespan of a1A//PC-a1ACTWTmice was significantly improved compare
in the figure), whereas all a1A/ pups died before P20.
(E–H) a1ACT expression improves cerebellar cortex and PC dendrites. Low pow
(green). The thickness of theML (F), the relative height of dendritic tree (G), and the
were reduced in a1A/ mice and partially corrected in a1A//PC-a1ACTWT m
*p < 0.05).
(I) Immunolabeling of PFs and PC dendrites using anti-vGlut1 (red) and anti-calb
(J) Immunolabeling of CFs and PC dendrites using anti-vGlut2 (red) and anti-calb
(K and L) Quantitation of CF reach (K) and relative height of dendritic tree (L) (100 C
tips of vGluT2-labeled CFs. Data are mean ± SEM.
See also Figure S5.at this synapse, which was surprising as PPRs generally reflect
presynaptic release probabilities, and a1ACT is present only
postsynaptically in a1A//PC-a1ACTWT mice, indicating thatd to a1A/ (*p < 0.05). Some pups survived until age of P30 (n = 2, not included
er images of cerebellar ML (E). PC dendrites are labeled for calbindin-28 kDa
density (as defined in the Experimental Procedures) of the PC dendritic tree (H)
ice (100 dendritic trees from five mice at each group. Control is set as one,
indin (green) antibodies.
indin (green) antibodies.
Fs, *p < 0.05). CF height wasmeasured from the apical pole of PC somata to the
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(legend on next page)
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factors either directly or indirectly related to the postsynaptic
target cell can also influence this parameter. Regardless, the
residual elevation of PPRs in a1A//PC-a1ACTWT mice sug-
gests that the incomplete restoration of PF-EPSC amplitude is
due to a presynaptic deficit in these mice.
The absence of any discernable effect of a1ACT expression on
CF-EPSCs indicates that actual P/Q-type Ca2+ channel function
is required for the process of CF maturation, as has been sug-
gested previously (Watanabe and Kano, 2011). Thus, it appears
that the phenotypic benefits of a1ACT expression are due
predominantly to the improvement in PF synaptic transmission.
a1ACTSCA6 Abolishes the Normal Function of a1ACT
in Gene Expression Regulation and Is Pathogenic
In Vitro and In Vivo
Compared to the properties of the normal a1ACT protein,
a1ACTWT, bearing 4 or 11 glutamines, the a1ACTSCA6 polypep-
tide had altered binding to the BTG1 enhancer, showing addi-
tional DNA-protein complexes, and lacked the capacity to
mediate expression via BTG1 and GRN luciferase reporters
and impaired expression of these genes in PC12 cells.
a1ACTSCA6 also failed to mediate neurite outgrowth when stably
expressed in PC12 cells and caused increased cell death. This
may explain why we did not obtain any mice with a1A//PC-
a1ACTSCA6 genotype. Mice overexpressing a1ACTSCA6 on a
normal background exhibited subtle but clearly measurable de-
fects in motor functioning. Computerized treadmill gait analysis
demonstrated progressive gait impairment with an increase in
double limb support, a compensatory reaction to instability dur-
ing walking. With advanced age, a1ACTSCA6 was associated
with thinning of the cerebellar cortex. These mice have reduced
levels of expression of TAF1, GRN, BTG1, and PMCA2, the
targets of a1ACT, relative to endogenous PC transcripts. These
studies suggest that, rather than arising from ion channel
dysfunction, the pathogenesis of SCA6 more closely resembles
the toxic gain-of-function mechanism of the polyQ disorders
(La Spada et al., 1991; Palhan et al., 2005; Sopher et al., 2004).
This is supported by the lack of disturbed Ca2+ channel function
in two mouse knockin studies of the SCA6 mutation (Saegusa
et al., 2007; Watase et al., 2008). If additional studies further
support this Ca2+ channel-independent mechanism, the demon-
stration of selective translation based on an IRES may pave the
way for therapies targeted at suppressing the IRES function.
We have shown that theCACNA1A gene is bicistronic, encod-
ing a newly identified transcription factor, a1ACT, involved with
neurite outgrowth and PC maturation, within the a1A mRNA.Figure 7. a1ACTSCA6 Is a Pathogenic Fragment
(A) Representative fluorescence dot blots of FITC-Annexin-V- and propidium iod
FLAG, and a1ACTSCA6-FLAG.
(B and C) Quantitation of Annexin-V- and PI-positive cells (*p < 0.05).
(D) Cell death as measured by LDH release assay (*p < 0.05).
(E) Expression levels of a1ACTWT and a1ACTSCA6 in cerebellar homogenates by
(F) Double support of hind paw was impaired in PC-a1ACTSCA6 transgenic mi
(**p < 0.01).
(G and H) Cerebellar cortical atrophy in PC-a1ACTSCA6 transgenic mice. Low pow
ML thickness (H) (*p < 0.05). PCs dendrites are labeled for calbindin (green).
(I) Schematic illustration of expression regulation and function of a1ACT. Data ar
See also Figure S6.a1ACT also bears the expanded polyQ tract in SCA6, which
interrupts transcription factor function, impairs viability of
cultured cells and is pathogenic in transgenic mice. These
findings are summarized in the diagram in Figure 7I.
EXPERIMENTAL PROCEDURES
Materials and Standard Protocols
Cells, animals/mouse strains, antibodies, plasmids, and other materials are
described in the Extended Experimental Procedures. The detailed protocols
used for ChIP, ChIP-based cloning, ChIP quantitative real-time PCR, EMSA,
luciferase assays, immunoprecipitation, immunohistochemistry, immunoblot-
ting, quantitative real-time PCR, electrophysiology, and LDH assay are
outlined in the Extended Experimental Procedures. This study involves spec-
imens from human subjects and was approved by the Institutional Review
Board of the University of Chicago Medical Center. All animal experiments
were approved and carried out in accordance with the regulations and guide-
lines for the care and use of experimental animals at the Institutional Animal
Care and Use Committee of the University of Chicago.
Protein Purification and Mass Spectrometry
Protein extracts from HEK293 cells stably transfected with a1A subunit
bearing a Q11 allele were separated via anion exchange chromatography
(HisTrap FF column) and further purified by ANTI-FLAGM2 affinity purification.
a1ACTWT fragment protein in SDS-PAGE gel was digested in-gel with trypsin,
and the resulting peptides were then analyzed via LC-MS/MS on an LTQ-
Velos-Orbitrap mass spectrometer. See details in the Extended Experimental
Procedures.
Immunohistochemistry and Microscopy
Detailed procedures of immunohistochemistry, antibodies, and dilutions are
described in the Extended Experimental Procedures. PC12 cells were imaged
0, 24, 48, and 72 hr after NGF 24 hr treatment. Neurites were defined as pro-
cesses longer than the width of the cell body. For each experiment, cells were
imaged. Dendrites were analyzed by employing ImageJ andNeuroJ programs.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, four tables, and three movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2013.05.059.
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